DAFNA Capital Management LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$932,228
-65.1%
734,038
-9.5%
0.29%
-60.2%
Q2 2023$2,667,680
+27.1%
810,845
+58.7%
0.73%
+15.7%
Q1 2023$2,099,647
-13.3%
510,863
+23.6%
0.63%
-7.6%
Q4 2022$2,422,893
-5.1%
413,463
+9.5%
0.68%
-0.7%
Q3 2022$2,554,000
+35.9%
377,763
-7.1%
0.69%
+34.2%
Q2 2022$1,879,000
+33.5%
406,763
+15.3%
0.51%
+39.5%
Q1 2022$1,408,000
+61.5%
352,763
+151.5%
0.37%
+67.6%
Q4 2021$872,000
-34.1%
140,2630.0%0.22%
-37.6%
Q3 2021$1,323,000
-24.1%
140,263
+9.4%
0.35%
-3.6%
Q2 2021$1,742,000
-13.4%
128,263
+3.2%
0.36%
-23.7%
Q1 2021$2,011,000
+53.4%
124,263
+152.2%
0.48%
+22.3%
Q4 2020$1,311,000
-53.9%
49,263
-67.8%
0.39%
-57.8%
Q3 2020$2,844,000
-55.0%
152,763
-43.5%
0.92%
-49.3%
Q2 2020$6,322,000
+170.1%
270,163
-32.7%
1.82%
+86.7%
Q1 2020$2,341,000
+277.0%
401,619
+270.3%
0.98%
+358.7%
Q4 2019$621,000
-21.7%
108,463
-78.4%
0.21%
-28.5%
Q3 2019$793,000
-28.9%
501,736
+82.3%
0.30%
-28.9%
Q2 2019$1,115,000
-47.4%
275,236
-31.8%
0.42%
-54.2%
Q1 2019$2,121,000403,3000.92%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders